drugset / Trial / NCT03942250

Uses of Irradiated Human Amniotic Membrane in the Treatment of Dystrophic Epidermolysis Bullosa Patients

NCT03942250 ↗

NaSingle-groupOpen-labelTreatment

Summary

To evaluate the effect of human amniotic membrane as a weekly dressing on chronic wounds in Epidermolysis Bullosa (EB) patients.

Timeline

Start
2017-01
Primary completion
2017-12
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Subject REGE pro Other / unclassified — Topical